Repligen Corp.
RGEN
Market Cap$6.68B
Close$
$57.62
53.6% downside
Current Fair Value
53.6% downsideOvervalued by 53.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.68 Billion |
|---|---|
| Enterprise Value | $6.51 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.46 |
| Beta | 1.11 |
| Outstanding Shares | 56,123,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -262.9 |
|---|---|
| PEG | -147.35 |
| Price to Sales | 11.29 |
| Price to Book Ratio | 3.55 |
| Enterprise Value to Revenue | 10.08 |
| Enterprise Value to EBIT | 319.92 |
| Enterprise Value to Net Income | -995 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Repligen Corp.
CEO: Anthony Hunt